CLEC6A (C-type lectin domain containing 6A) - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: CLEC6A (C-type lectin domain containing 6A) Homo sapiens
Analyze
Symbol: CLEC6A
Name: C-type lectin domain containing 6A
RGD ID: 1351045
HGNC Page HGNC:14556
Description: Enables D-mannose binding activity; calcium ion binding activity; and pattern recognition receptor activity. Predicted to be involved in several processes, including positive regulation of canonical NF-kappaB signal transduction; positive regulation of immune response; and response to fungus. Is active in plasma membrane.
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: C-type (calcium dependent, carbohydrate-recognition domain) lectin, superfamily member 10; C-type lectin domain family 6 member A; C-type lectin domain family 6, member A; C-type lectin superfamily member 10; CLEC4N; CLECSF10; DC-associated C-type lectin 2; DC-associated C-type lectin-2; dectin 2; dectin-2; dendritic cell-associated C-type lectin 2; hDECTIN-2
RGD Orthologs
Mouse
Rat
Bonobo
Green Monkey
Alliance Orthologs
More Info more info ...
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38128,455,962 - 8,478,330 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl128,455,962 - 8,478,330 (+)EnsemblGRCh38hg38GRCh38
GRCh37128,608,558 - 8,630,926 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36128,499,858 - 8,522,193 (+)NCBINCBI36Build 36hg18NCBI36
Build 34128,499,857 - 8,522,193NCBI
Celera1210,144,899 - 10,166,924 (+)NCBICelera
Cytogenetic Map12p13.31NCBI
HuRef128,391,249 - 8,413,275 (+)NCBIHuRef
CHM1_1128,577,549 - 8,599,900 (+)NCBICHM1_1
T2T-CHM13v2.0128,439,728 - 8,461,787 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


References

References - curated
# Reference Title Reference Citation
1. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:12477932   PMID:15175046   PMID:15368084   PMID:15481152   PMID:15810886   PMID:16423983   PMID:19665392   PMID:21283787   PMID:21677049   PMID:21873635   PMID:23573288   PMID:23606632  
PMID:23911656   PMID:23928558   PMID:23932568   PMID:24129160   PMID:24362892   PMID:25659141   PMID:26129889   PMID:27358401   PMID:27872290   PMID:28652405   PMID:29616019   PMID:29668708  
PMID:30443026   PMID:31371767   PMID:31868000   PMID:36078084   PMID:37813965  


Genomics

Comparative Map Data
CLEC6A
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38128,455,962 - 8,478,330 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl128,455,962 - 8,478,330 (+)EnsemblGRCh38hg38GRCh38
GRCh37128,608,558 - 8,630,926 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36128,499,858 - 8,522,193 (+)NCBINCBI36Build 36hg18NCBI36
Build 34128,499,857 - 8,522,193NCBI
Celera1210,144,899 - 10,166,924 (+)NCBICelera
Cytogenetic Map12p13.31NCBI
HuRef128,391,249 - 8,413,275 (+)NCBIHuRef
CHM1_1128,577,549 - 8,599,900 (+)NCBICHM1_1
T2T-CHM13v2.0128,439,728 - 8,461,787 (+)NCBIT2T-CHM13v2.0
Clec4n
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm396123,206,802 - 123,223,983 (+)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl6123,206,802 - 123,223,980 (+)EnsemblGRCm39 Ensembl
GRCm386123,229,843 - 123,247,024 (+)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl6123,229,843 - 123,247,021 (+)EnsemblGRCm38mm10GRCm38
MGSCv376123,179,861 - 123,197,042 (+)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv366123,195,493 - 123,212,640 (+)NCBIMGSCv36mm8
Celera6125,027,700 - 125,044,646 (+)NCBICelera
Cytogenetic Map6F2NCBI
cM Map658.3NCBI
Clec6a-ps1
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCr84158,225,100 - 158,244,722 (+)NCBIGRCr8
mRatBN7.24156,539,408 - 156,559,032 (+)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl4156,539,408 - 156,558,605 (+)NCBImRatBN7.2 Ensembl
mRatBN7.2 Ensembl4156,539,408 - 156,558,605 (+)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx4162,808,935 - 162,813,516 (+)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.04158,591,814 - 158,596,395 (+)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.04157,237,232 - 157,241,810 (+)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.04156,186,251 - 156,219,375 (+)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl4156,186,281 - 156,219,346 (+)NCBIRnor6.0rn6Rnor6.0
Rnor_5.04223,202,953 - 223,236,018 (+)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.44159,822,460 - 159,841,743 (+)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.14160,067,395 - 160,086,679 (+)NCBI
Celera4145,336,271 - 145,352,372 (+)NCBICelera
Cytogenetic Map4q42NCBI
CLEC6A
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan1-v21013,979,106 - 14,002,512 (+)NCBINHGRI_mPanPan1-v2
NHGRI_mPanPan11213,975,866 - 13,999,272 (+)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0128,537,766 - 8,560,736 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1128,752,778 - 8,775,738 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl128,752,778 - 8,775,738 (+)Ensemblpanpan1.1panPan2
CLEC6A
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.1118,227,590 - 8,250,857 (+)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl118,228,381 - 8,253,159 (+)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_023666089325,571 - 349,303 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0

Variants

.
Variants in CLEC6A
8 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 12p13.33-11.22(chr12:121055-28415184)x1 copy number loss See cases [RCV000052776] Chr12:121055..28415184 [GRCh38]
Chr12:282465..28568117 [GRCh37]
Chr12:100482..28459384 [NCBI36]
Chr12:12p13.33-11.22
pathogenic
GRCh38/hg38 12p13.33-11.1(chr12:77187-34380176)x3 copy number gain See cases [RCV000053660] Chr12:77187..34380176 [GRCh38]
Chr12:282465..34533111 [GRCh37]
Chr12:56614..34424378 [NCBI36]
Chr12:12p13.33-11.1
pathogenic
GRCh38/hg38 12p13.33-12.1(chr12:80412-25470329)x3 copy number gain See cases [RCV000053662] Chr12:80412..25470329 [GRCh38]
Chr12:282465..25623263 [GRCh37]
Chr12:59839..25514530 [NCBI36]
Chr12:12p13.33-12.1
pathogenic
GRCh38/hg38 12p13.33-11.1(chr12:212976-33926913)x4 copy number gain See cases [RCV000053666] Chr12:212976..33926913 [GRCh38]
Chr12:322142..34079848 [GRCh37]
Chr12:192403..33971115 [NCBI36]
Chr12:12p13.33-11.1
pathogenic
GRCh38/hg38 12p13.33-11.1(chr12:121255-34603274)x3 copy number gain See cases [RCV000136611] Chr12:121255..34603274 [GRCh38]
Chr12:282465..34756209 [GRCh37]
Chr12:100682..34647476 [NCBI36]
Chr12:12p13.33-11.1
pathogenic
GRCh38/hg38 12p13.33-12.3(chr12:2871741-14987348)x3 copy number gain See cases [RCV000137694] Chr12:2871741..14987348 [GRCh38]
Chr12:2980907..15140282 [GRCh37]
Chr12:2851168..15031549 [NCBI36]
Chr12:12p13.33-12.3
pathogenic
GRCh38/hg38 12p13.33-11.1(chr12:121271-34603261)x3 copy number gain See cases [RCV000139052] Chr12:121271..34603261 [GRCh38]
Chr12:282465..34756196 [GRCh37]
Chr12:100698..34647463 [NCBI36]
Chr12:12p13.33-11.1
pathogenic
GRCh38/hg38 12p13.33-11.1(chr12:54427-34608071)x4 copy number gain See cases [RCV000139787] Chr12:54427..34608071 [GRCh38]
Chr12:282465..34761006 [GRCh37]
Chr12:33854..34652273 [NCBI36]
Chr12:12p13.33-11.1
pathogenic
GRCh38/hg38 12p13.33-q24.33(chr12:121271-133196807)x3 copy number gain See cases [RCV000139555] Chr12:121271..133196807 [GRCh38]
Chr12:282465..133773393 [GRCh37]
Chr12:100698..132283466 [NCBI36]
Chr12:12p13.33-q24.33
pathogenic
GRCh38/hg38 12p13.31(chr12:8455575-8623334)x1 copy number loss See cases [RCV000141172] Chr12:8455575..8623334 [GRCh38]
Chr12:8608171..8775930 [GRCh37]
Chr12:8499438..8667197 [NCBI36]
Chr12:12p13.31
likely benign
GRCh38/hg38 12p13.33-12.2(chr12:1258274-20657577)x3 copy number gain See cases [RCV000141905] Chr12:1258274..20657577 [GRCh38]
Chr12:1367440..20810511 [GRCh37]
Chr12:1237701..20701778 [NCBI36]
Chr12:12p13.33-12.2
pathogenic
GRCh38/hg38 12p13.33-11.1(chr12:64620-34682902)x4 copy number gain See cases [RCV000142149] Chr12:64620..34682902 [GRCh38]
Chr12:173786..34835837 [GRCh37]
Chr12:44047..34727104 [NCBI36]
Chr12:12p13.33-11.1
pathogenic
GRCh37/hg19 12p13.33-11.1(chr12:148034-34178799)x4 copy number gain See cases [RCV000240164] Chr12:148034..34178799 [GRCh37]
Chr12:12p13.33-11.1
pathogenic
GRCh37/hg19 12p13.33-q24.33(chr12:1-133851895)x3 copy number gain See cases [RCV000258805] Chr12:1..133851895 [GRCh37]
Chr12:12p13.33-q24.33
pathogenic|likely pathogenic
GRCh37/hg19 12p13.33-11.1(chr12:89061-34178799)x3 copy number gain See cases [RCV000240487] Chr12:89061..34178799 [GRCh37]
Chr12:12p13.33-11.1
pathogenic
NC_000012.12:g.(1_3750000)_(5250000_9000000)del deletion Tumoral calcinosis, hyperphosphatemic, familial, 1 [RCV000758697] Chr12:3750000..5250000 [GRCh38]
Chr12:12p13.33-13.31
pathogenic|not provided
GRCh37/hg19 12p13.33-q11(chr12:173786-37869301)x3 copy number gain See cases [RCV000449191] Chr12:173786..37869301 [GRCh37]
Chr12:12p13.33-q11
pathogenic
GRCh37/hg19 12p13.33-12.1(chr12:173786-25286865)x3 copy number gain See cases [RCV000449287] Chr12:173786..25286865 [GRCh37]
Chr12:12p13.33-12.1
pathogenic
GRCh37/hg19 12p13.33-11.1(chr12:173786-34835837)x3 copy number gain See cases [RCV000447551] Chr12:173786..34835837 [GRCh37]
Chr12:12p13.33-11.1
pathogenic
GRCh37/hg19 12p13.33-12.2(chr12:173786-20026080)x3 copy number gain See cases [RCV000446050] Chr12:173786..20026080 [GRCh37]
Chr12:12p13.33-12.2
pathogenic
GRCh37/hg19 12p13.31(chr12:8608171-8765397) copy number loss See cases [RCV000447204] Chr12:8608171..8765397 [GRCh37]
Chr12:12p13.31
uncertain significance
GRCh37/hg19 12p13.33-11.1(chr12:189578-34756150) copy number gain See cases [RCV000446017] Chr12:189578..34756150 [GRCh37]
Chr12:12p13.33-11.1
pathogenic
GRCh37/hg19 12p13.31(chr12:7770670-8646662)x3 copy number gain See cases [RCV000448032] Chr12:7770670..8646662 [GRCh37]
Chr12:12p13.31
likely benign
GRCh37/hg19 12p13.33-q24.33(chr12:173787-133777902)x3 copy number gain See cases [RCV000510482] Chr12:173787..133777902 [GRCh37]
Chr12:12p13.33-q24.33
pathogenic
GRCh37/hg19 12p13.33-11.1(chr12:565369-34835837)x3 copy number gain See cases [RCV000511580] Chr12:565369..34835837 [GRCh37]
Chr12:12p13.33-11.1
likely pathogenic
GRCh37/hg19 12p13.33-q24.33(chr12:173787-133777902) copy number gain See cases [RCV000511643] Chr12:173787..133777902 [GRCh37]
Chr12:12p13.33-q24.33
pathogenic
GRCh37/hg19 12p13.33-13.2(chr12:173786-11677456)x3 copy number gain See cases [RCV000510853] Chr12:173786..11677456 [GRCh37]
Chr12:12p13.33-13.2
pathogenic
GRCh37/hg19 12p13.33-11.22(chr12:173786-28219229)x3 copy number gain See cases [RCV000510961] Chr12:173786..28219229 [GRCh37]
Chr12:12p13.33-11.22
pathogenic
GRCh37/hg19 12p13.33-11.1(chr12:173786-34835837)x3 copy number gain not provided [RCV000683479] Chr12:173786..34835837 [GRCh37]
Chr12:12p13.33-11.1
pathogenic
GRCh37/hg19 12p13.33-11.1(chr12:173786-34835837)x2,3 copy number gain not provided [RCV000683478] Chr12:173786..34835837 [GRCh37]
Chr12:12p13.33-11.1
pathogenic
GRCh37/hg19 12p13.33-q11(chr12:173786-37869107)x3 copy number gain not provided [RCV000683480] Chr12:173786..37869107 [GRCh37]
Chr12:12p13.33-q11
pathogenic
GRCh37/hg19 12p13.33-q24.33(chr12:191619-133777645)x3 copy number gain not provided [RCV000750246] Chr12:191619..133777645 [GRCh37]
Chr12:12p13.33-q24.33
pathogenic
GRCh37/hg19 12p13.33-q24.33(chr12:621220-133779118)x3 copy number gain not provided [RCV000750253] Chr12:621220..133779118 [GRCh37]
Chr12:12p13.33-q24.33
pathogenic
GRCh37/hg19 12p13.31(chr12:8029351-8705395)x3 copy number gain not provided [RCV000737754] Chr12:8029351..8705395 [GRCh37]
Chr12:12p13.31
benign
GRCh37/hg19 12p13.31(chr12:8323135-8654067)x3 copy number gain not provided [RCV000737757] Chr12:8323135..8654067 [GRCh37]
Chr12:12p13.31
benign
GRCh37/hg19 12p13.31(chr12:8325638-8654067)x3 copy number gain not provided [RCV000737759] Chr12:8325638..8654067 [GRCh37]
Chr12:12p13.31
benign
GRCh37/hg19 12p13.31(chr12:8548989-8654067)x3 copy number gain not provided [RCV000737762] Chr12:8548989..8654067 [GRCh37]
Chr12:12p13.31
benign
GRCh37/hg19 12p13.33-11.21(chr12:191619-31733044)x3 copy number gain not provided [RCV000750245] Chr12:191619..31733044 [GRCh37]
Chr12:12p13.33-11.21
pathogenic
GRCh37/hg19 12p13.31(chr12:6911437-9381254)x3 copy number gain not provided [RCV000750277] Chr12:6911437..9381254 [GRCh37]
Chr12:12p13.31
uncertain significance
GRCh37/hg19 12p13.31(chr12:8511575-8654067)x3 copy number gain not provided [RCV000750292] Chr12:8511575..8654067 [GRCh37]
Chr12:12p13.31
benign
NC_000012.12:g.(?_8456112)_(8612767_?)del deletion Hyper-IgM syndrome type 2 [RCV001031871] Chr12:8608708..8765363 [GRCh37]
Chr12:12p13.31
pathogenic
GRCh37/hg19 12p13.33-12.3(chr12:189216-15001420) copy number gain not provided [RCV000767817] Chr12:189216..15001420 [GRCh37]
Chr12:12p13.33-12.3
pathogenic
GRCh37/hg19 12p13.33-11.1(chr12:173786-34496628)x3 copy number gain not provided [RCV000847209] Chr12:173786..34496628 [GRCh37]
Chr12:12p13.33-11.1
pathogenic
NC_000012.11:g.(?_6945914)_(9027627_?)dup duplication Temtamy syndrome [RCV000816630] Chr12:6945914..9027627 [GRCh37]
Chr12:12p13.31
uncertain significance
NC_000012.11:g.(?_4368352)_(9027607_?)dup duplication Lymphoproliferative syndrome 2 [RCV003105682] Chr12:4368352..9027607 [GRCh37]
Chr12:12p13.32-13.31
uncertain significance
GRCh37/hg19 12p13.33-q11(chr12:274676-37869301)x4 copy number gain not provided [RCV001006470] Chr12:274676..37869301 [GRCh37]
Chr12:12p13.33-q11
pathogenic
NC_000012.11:g.(?_6945914)_(9027627_?)dup duplication Developmental and epileptic encephalopathy, 21 [RCV001325295]|Klippel-Feil syndrome 3, autosomal dominant [RCV001301079]|Temtamy syndrome [RCV000816630]|not provided [RCV001859243] Chr12:6945914..9027627 [GRCh37]
Chr12:12p13.31
uncertain significance|no classifications from unflagged records
NC_000012.11:g.(?_6438478)_(8756953_?)dup duplication not provided [RCV001970781] Chr12:6438478..8756953 [GRCh37]
Chr12:12p13.31
uncertain significance
GRCh37/hg19 12p13.33-11.1(chr12:173786-34835837) copy number gain not specified [RCV002052957] Chr12:173786..34835837 [GRCh37]
Chr12:12p13.33-11.1
pathogenic
GRCh37/hg19 12p13.33-12.1(chr12:173786-25286865) copy number gain not specified [RCV002052955] Chr12:173786..25286865 [GRCh37]
Chr12:12p13.33-12.1
pathogenic
GRCh37/hg19 12p13.33-q11(chr12:173786-37869301) copy number gain not specified [RCV002052958] Chr12:173786..37869301 [GRCh37]
Chr12:12p13.33-q11
pathogenic
NC_000012.11:g.(?_6978008)_(9010204_?)dup duplication Peroxisome biogenesis disorder 2B [RCV001877402] Chr12:6978008..9010204 [GRCh37]
Chr12:12p13.31
uncertain significance
NC_000012.11:g.(?_6438478)_(9027607_?)dup duplication not provided [RCV001943267] Chr12:6438478..9027607 [GRCh37]
Chr12:12p13.31
uncertain significance
NM_001007033.2(CLEC6A):c.436A>G (p.Asn146Asp) single nucleotide variant not specified [RCV004189402] Chr12:8476191 [GRCh38]
Chr12:8628787 [GRCh37]
Chr12:12p13.31
uncertain significance
NM_001007033.2(CLEC6A):c.509A>G (p.Asn170Ser) single nucleotide variant not specified [RCV004085337] Chr12:8477343 [GRCh38]
Chr12:8629939 [GRCh37]
Chr12:12p13.31
uncertain significance
NM_001007033.2(CLEC6A):c.330G>A (p.Met110Ile) single nucleotide variant not specified [RCV004201196] Chr12:8465590 [GRCh38]
Chr12:8618186 [GRCh37]
Chr12:12p13.31
uncertain significance
GRCh37/hg19 12p13.33-11.1(chr12:176047-34179852)x4 copy number gain Pallister-Killian syndrome [RCV003154827] Chr12:176047..34179852 [GRCh37]
Chr12:12p13.33-11.1
pathogenic
NM_001007033.2(CLEC6A):c.467C>T (p.Pro156Leu) single nucleotide variant not specified [RCV004270845] Chr12:8476222 [GRCh38]
Chr12:8628818 [GRCh37]
Chr12:12p13.31
uncertain significance
NM_001007033.2(CLEC6A):c.427C>A (p.Pro143Thr) single nucleotide variant not specified [RCV004257351] Chr12:8476182 [GRCh38]
Chr12:8628778 [GRCh37]
Chr12:12p13.31
uncertain significance
NM_001007033.2(CLEC6A):c.295G>T (p.Val99Phe) single nucleotide variant not specified [RCV004362259] Chr12:8465555 [GRCh38]
Chr12:8618151 [GRCh37]
Chr12:12p13.31
likely benign
Single allele duplication not provided [RCV003448692] Chr12:188053..34856694 [GRCh37]
Chr12:12p13.33-11.1
pathogenic
GRCh37/hg19 12p13.33-11.1(chr12:173786-34835641)x3 copy number gain not specified [RCV003986979] Chr12:173786..34835641 [GRCh37]
Chr12:12p13.33-11.1
pathogenic
NM_001007033.2(CLEC6A):c.394G>A (p.Glu132Lys) single nucleotide variant not specified [RCV004437041] Chr12:8476149 [GRCh38]
Chr12:8628745 [GRCh37]
Chr12:12p13.31
uncertain significance
NM_001007033.2(CLEC6A):c.574G>T (p.Val192Phe) single nucleotide variant not specified [RCV004613000] Chr12:8477408 [GRCh38]
Chr12:8630004 [GRCh37]
Chr12:12p13.31
uncertain significance
NC_000012.11:g.(?_7053285)_(9027607_?)del deletion Developmental and epileptic encephalopathy, 21 [RCV004578381]|Peroxisome biogenesis disorder 2B [RCV004578380] Chr12:7053285..9027607 [GRCh37]
Chr12:12p13.31
pathogenic
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:248
Count of miRNA genes:209
Interacting mature miRNAs:217
Transcripts:ENST00000382073
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


Expression

RNA-SEQ Expression

adipose tissue
alimentary part of gastrointestinal system
appendage
circulatory system
ectoderm
endocrine system
endoderm
entire extraembryonic component
exocrine system
hemolymphoid system
hepatobiliary system
integumental system
mesenchyme
mesoderm
musculoskeletal system
nervous system
renal system
reproductive system
respiratory system
sensory system
423 418 406 458 799 397 945 2 143 1335 114 553 2386 2370 7 544 271 654 778 30

Sequence


Ensembl Acc Id: ENST00000382073   ⟹   ENSP00000371505
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl128,455,962 - 8,478,330 (+)Ensembl
RefSeq Acc Id: NM_001007033   ⟹   NP_001007034
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38128,455,962 - 8,478,330 (+)NCBI
GRCh37128,608,591 - 8,630,926 (+)RGD
Build 36128,499,858 - 8,522,193 (+)NCBI Archive
Celera1210,144,899 - 10,166,924 (+)RGD
HuRef128,391,249 - 8,413,275 (+)RGD
CHM1_1128,577,549 - 8,599,900 (+)NCBI
T2T-CHM13v2.0128,439,728 - 8,461,787 (+)NCBI
Sequence:
RefSeq Acc Id: NM_001317999   ⟹   NP_001304928
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38128,455,962 - 8,478,330 (+)NCBI
CHM1_1128,577,549 - 8,599,900 (+)NCBI
T2T-CHM13v2.0128,439,728 - 8,461,787 (+)NCBI
Sequence:
RefSeq Acc Id: NP_001007034   ⟸   NM_001007033
- Peptide Label: isoform 1
- UniProtKB: A2RUK3 (UniProtKB/Swiss-Prot),   Q6EIG7 (UniProtKB/Swiss-Prot)
- Sequence:
RefSeq Acc Id: NP_001304928   ⟸   NM_001317999
- Peptide Label: isoform 2
- UniProtKB: Q6EIG7 (UniProtKB/Swiss-Prot)
- Sequence:
Ensembl Acc Id: ENSP00000371505   ⟸   ENST00000382073
Protein Domains
C-type lectin

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-Q6EIG7-F1-model_v2 AlphaFold Q6EIG7 1-209 view protein structure

Promoters
RGD ID:7223069
Promoter ID:EPDNEW_H17281
Type:initiation region
Name:CLEC6A_1
Description:C-type lectin domain containing 6A
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh38128,455,987 - 8,456,047EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:14556 AgrOrtholog
COSMIC CLEC6A COSMIC
Ensembl Genes ENSG00000205846 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript ENST00000382073 ENTREZGENE
  ENST00000382073.4 UniProtKB/Swiss-Prot
Gene3D-CATH 3.10.100.10 UniProtKB/Swiss-Prot
GTEx ENSG00000205846 GTEx
HGNC ID HGNC:14556 ENTREZGENE
Human Proteome Map CLEC6A Human Proteome Map
InterPro C-type_lectin-like UniProtKB/Swiss-Prot
  C-type_lectin-like/link_sf UniProtKB/Swiss-Prot
  C-type_lectin/snaclec_domain UniProtKB/Swiss-Prot
  CD209-like_CTLD UniProtKB/Swiss-Prot
  CTDL_fold UniProtKB/Swiss-Prot
KEGG Report hsa:93978 UniProtKB/Swiss-Prot
NCBI Gene 93978 ENTREZGENE
OMIM 613579 OMIM
PANTHER C-TYPE LECTIN DOMAIN FAMILY 19 MEMBER A-RELATED UniProtKB/Swiss-Prot
  MANNOSE, PHOSPHOLIPASE, LECTIN RECEPTOR RELATED UniProtKB/Swiss-Prot
Pfam Lectin_C UniProtKB/Swiss-Prot
PharmGKB PA26579 PharmGKB
PROSITE C_TYPE_LECTIN_2 UniProtKB/Swiss-Prot
SMART CLECT UniProtKB/Swiss-Prot
Superfamily-SCOP SSF56436 UniProtKB/Swiss-Prot
UniProt A2RUK3 ENTREZGENE
  CLC6A_HUMAN UniProtKB/Swiss-Prot, ENTREZGENE
UniProt Secondary A2RUK3 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2017-03-28 CLEC6A  C-type lectin domain containing 6A    C-type lectin domain family 6 member A  Symbol and/or name change 5135510 APPROVED
2015-12-22 CLEC6A  C-type lectin domain family 6 member A    C-type lectin domain family 6, member A  Symbol and/or name change 5135510 APPROVED